Sempra (SRE) delivered a clean beat on the line that matters most for a regulated utility. Adjusted earnings of $1.40 per share topped the $1.20 consensus by 14.8% and cleared the $1.22 Earnings Whisper number, while growing 26.1% from $1.11 a year ago. Revenue of $3.191 billion missed the $3.35 billion consensus by 4.7% and grew only 1.3%. Management responded by steering 2026 adjusted EPS to the high end of its $4.80-$5.30 range. The central tension is geographic. Texas is producing more growth and capital opportunity than investors were modeling, while California just handed Sempra a regulatory setback that tilts 2027 toward the bottom half of guidance.

The quality of the beat holds up well. The top-line miss matters less than it looks, because much of the shortfall sits in natural gas utility revenue and energy-related businesses. Lower gas costs and reduced deliveries (183 Bcf versus 197 Bcf) flow through to customers in those lines, and the Ecogas sale removed revenue in August. The earnings engine was Sempra Texas Utilities, where segment earnings jumped to $460 million from $306 million. New Oncor base rates drove that gain, built on a 9.75% ROE and a 43.5% equity layer. Lower consolidated interest expense, $298 million versus $403 million, also helped. GAAP results were noisier. GAAP EPS of $1.34 compared with just $0.12 a year ago, when $514 million of held-for-sale tax charges depressed results. This quarter's GAAP figure absorbed a $149 million after-tax charge from CPUC proposed decisions on Track 3 and TIMP, partly offset by a $97 million gain on the Ecogas sale. That disallowance cut California's GAAP segment earnings to $223 million from $370 million, an early warning about the regulatory climate in the state.

The growth trajectory has clearly improved over the year. Adjusted EPS rose only modestly in the first quarter ($1.51 versus $1.44), then strengthened sharply in the second ($1.16 versus $0.89). Growth remained robust in the third. The call reinforced that Texas is the driver. Year-over-year growth in Texas equity earnings expanded from $25 million in Q1 to $138 million in Q2 and $154 million in Q3. Guidance language moved from simply 'affirmed' in each prior report to 'high end' now, a meaningful upgrade in tone.

The forward story is where the call added the most. Oncor now expects its 2027-2031 base capital plan to rise roughly 20% from the current $47.5 billion. In the second quarter, management said only that the plan would go up. That figure still excludes the Eastern 765-kV STEP, SRP and all Batch Zero load, so further upside remains. Supporting evidence was abundant:

• Oncor set a 33.3 GW peak, up 6%.
• Roughly 24 GW of large load was classified as base load in ERCOT's Batch Zero process.
• The non-data-center large-load pipeline grew to 19 GW from about 16 GW.
• The PUCT approved both Import Path 1 segments, worth about $3.9 billion, although rehearing motions have been filed.

The 45% SI Partners sale to KKR, which slipped earlier this year, is now expected to close within two weeks, supporting debt reduction and simplification.

Bears have legitimate ammunition, and most of it points at 2027. A CPUC proposed decision denies correction of the 2024 GRC attrition mechanism, worth about $188 million of revenue requirement. If it stands, California's 2027 segment earnings fall to the low end of their range and Sempra's $5.10-$5.70 2027 EPS range shifts to its lower half, unless management mitigates the impact. Management framed the hit as a 2027-only issue. Other risks are also building:

• The PUCT remanded Import Path 2.
• ERCOT sent follow-up information requests to about 80% of Batch Zero customers.
• Texas O&M inflation is running 1 to 1.5 points above the national average.
• Post-election Texas politics introduced uncertainty that management repeatedly called 'too early to tell.'
• Confidence in California wildfire legislation has softened to 'this fall or next spring.'

Investor expectations shifted noticeably heading into the report. Earnings Whispers sentiment moved from essentially neutral (-0.01) to clearly positive (0.31). The stock has not followed. At $82.90 ahead of the release, shares were down 2.1% since the opening after the August report and 7.2% below their 200-day moving average of $89.37. They sat in the middle of an inter-earnings range that ran from $88.14 in August to a 52-week low of $76.21 on September 29. The rebound of roughly 9% off that low shows buyers returning, but the market has not yet rewarded the Texas growth story.

The bottom line is that Sempra's third quarter strengthened the near-term and long-range investment case, built on a high-end 2026 outlook and a quantified Oncor capital step-up that still leaves upside. California regulation and Texas politics now define the risk around 2027. With sentiment improving but shares still below long-term trend, the market appears to be waiting for the SI Partners close and February's capital plan before fully crediting the Texas growth story.